UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of an algorithm incorporating pharmacokinetics of adalimumab in inflammatory bowel diseases

The American journal of gastroenterology, 2014-08, Vol.109 (8), p.1250-1256

2014

Volltextzugriff (PDF)

La réduction des volumes ou l’intensité de la réponse tumorale en cancérologie colorectale

Oncologie (Paris, France), 2014-12, Vol.16 (11-12), p.587-592

2014

Volltextzugriff (PDF)

Clinical considerations for DPD deficiency testing in advanced cancer patients: tumor lysis syndrome should be considered as a major interference

Annals of oncology, 2022-08, Vol.33 (8), p.850-852

2022

Volltextzugriff (PDF)

Surveillance of colorectal cancers following curative-intent surgery: "Whatever the cost?"

Digestive and liver disease, 2022-03, Vol.54 (3), p.293-295

2022

Volltextzugriff (PDF)

Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open‐label, prospective and randomised clinical trial

Alimentary pharmacology & therapeutics, 2017-07, Vol.46 (2), p.142-149

2017

Volltextzugriff (PDF)

PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer

PloS one, 2020-12, Vol.15 (12), p.e0243997

2020

Volltextzugriff (PDF)

Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2015-07, Vol.9 (7), p.525-531

2015

Volltextzugriff (PDF)

Why do guidelines supersede the conference consensus?: New French recommendations for metastatic colorectal cancer management

Digestive and liver disease, 2019-10, Vol.51 (10), p.1364-1365

2019

Volltextzugriff (PDF)

Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course

Journal of Crohn's and colitis, 2015-06, Vol.9 (6), p.445-451

2015

Volltextzugriff (PDF)

Enquête d’opinion au CHU de Saint-Étienne sur la pratique des autopsies médicales : faut-il réviser la loi de 2004 relative à la bioéthique ?

La revue de medecine interne, 2011-04, Vol.32 (4), p.205-211

2011

Volltextzugriff (PDF)

Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019-05, Vol.22 (3), p.577-586

2019

Volltextzugriff (PDF)

Incidence and management of malignant digestive endocrine tumours in a well defined French population

Gut, 2004-04, Vol.53 (4), p.549-553

2004

Volltextzugriff (PDF)

Drug interaction between infliximab and azathioprine in patients with Crohn's disease

Alimentary pharmacology & therapeutics, 2003-11, Vol.18 (9), p.917-925

2003

Volltextzugriff (PDF)

Exploratory analyses of 400 patients enrolled in 2 FFCD trials of first line treatment for metastatic pancreatic cancer

Annals of oncology, 2018-10, Vol.29, p.viii244-viii244

2018

Volltextzugriff (PDF)

Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer (mCRC): Preliminary results from the phase IIIb, international, open-label, early-access PRECONNECT study

Annals of oncology, 2018-06, Vol.29, p.v104-v105

2018

Volltextzugriff (PDF)

Colon cancer in France: evidence for improvement in management and survival

Gut, 2002-07, Vol.51 (1), p.60-64

2002

Volltextzugriff (PDF)

Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer - PRODIGE 13 a FFCD and Unicancer phase III trial: baseline characteristics

Annals of oncology, 2016-10, Vol.27, p.vi159-vi159

2016

Volltextzugriff (PDF)

6‐Tioguanine monitoring in steroid‐dependent patients with inflammatory bowel diseases receiving azathioprine

Alimentary pharmacology & therapeutics, 2005-04, Vol.21 (7), p.829-839

2005

Volltextzugriff (PDF)

Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey

Alimentary pharmacology & therapeutics, 2009-10, Vol.30 (8), p.854-863

2009

Volltextzugriff (PDF)

Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn’s disease

Alimentary Pharmacology and Therapeutics, 2007-04, Vol.25 (7), p.797-804

2007

Volltextzugriff (PDF)

La réduction des volumes ou l'intensité de la réponse tumorale en cancérologie colorectale: DOSSIER DPC/CME : Le cancer du côlon : du dépistage de masse au traitement personnalisé

Oncologie (Paris, France), 2014, Vol.16 (11-12), p.587-592

2014

Volltextzugriff (PDF)

Appendicectomy as a potential therapy for refractory ulcerative proctitis

Alimentary pharmacology & therapeutics, 2011-07, Vol.34 (2), p.257-258

2011

Volltextzugriff (PDF)

L’estomac pastèque : une cause rare d’anémie ferriprive, de traitement chirurgical ; un nouveau cas et revue de la littérature

Annales de chirurgie, 2003, Vol.128 (7), p.462-464

2003

Volltextzugriff (PDF)

P-125 Current practices in metastatic colorectal cancer: Results from the real-world screening and consensus based on practices and evidence (SCOPE) program in gastrointestinal cancers

Annals of oncology, 2023-06, Vol.34, p.S58-S59

2023

Volltextzugriff (PDF)

1 – 25 von 301

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Französisch
(190)
Englisch
(111)

Erscheinungsjahr

n.n

Thema

Humans
(169)
Male
(102)
Female
(94)
Middle Aged
(93)
Adult
(74)
Aged
(67)
Science & Technology
(59)
Life Sciences & Biomedicine
(56)
Sciences Biologiques Et Medicales
(35)
Sciences Medicales
(34)
Gastroenterology & Hepatology
(26)
Life Sciences
(22)
Biological And Medical Sciences
(19)
Medical Sciences
(19)
Aged, 80 And Over
(15)
Treatment Outcome
(15)
Gastroenterologie. Foie. Pancreas. Abdomen
(14)
Oncology
(14)
Radiography
(14)
Adolescent
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of an algorithm incorporating pharmacokinetics of adalimumab in inflammatory bowel diseases

La réduction des volumes ou l’intensité de la réponse tumorale en cancérologie colorectale

Clinical considerations for DPD deficiency testing in advanced cancer patients: tumor lysis syndrome should be considered as a major interference

Surveillance of colorectal cancers following curative-intent surgery: "Whatever the cost?"

Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open‐label, prospective and randomised clinical trial

PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer

Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease

Why do guidelines supersede the conference consensus?: New French recommendations for metastatic colorectal cancer management

Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course

Enquête d’opinion au CHU de Saint-Étienne sur la pratique des autopsies médicales : faut-il réviser la loi de 2004 relative à la bioéthique ?

Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial

Incidence and management of malignant digestive endocrine tumours in a well defined French population

Drug interaction between infliximab and azathioprine in patients with Crohn's disease

Exploratory analyses of 400 patients enrolled in 2 FFCD trials of first line treatment for metastatic pancreatic cancer

Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer (mCRC): Preliminary results from the phase IIIb, international, open-label, early-access PRECONNECT study

Colon cancer in France: evidence for improvement in management and survival

Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer - PRODIGE 13 a FFCD and Unicancer phase III trial: baseline characteristics

6‐Tioguanine monitoring in steroid‐dependent patients with inflammatory bowel diseases receiving azathioprine

Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey

Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn’s disease

La réduction des volumes ou l'intensité de la réponse tumorale en cancérologie colorectale: DOSSIER DPC/CME : Le cancer du côlon : du dépistage de masse au traitement personnalisé

Appendicectomy as a potential therapy for refractory ulcerative proctitis

Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial – Prodige 31 REMINET: An FFCD study

L’estomac pastèque : une cause rare d’anémie ferriprive, de traitement chirurgical ; un nouveau cas et revue de la littérature

P-125 Current practices in metastatic colorectal cancer: Results from the real-world screening and consensus based on practices and evidence (SCOPE) program in gastrointestinal cancers

Suchergebnisse filtern